Alkermes plc (ALKS) vs Ionis Pharmaceuticals, Inc. (IONS)

A side-by-side comparison of Alkermes plc and Ionis Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALKS vs IONS

growth of $100 · dividends reinvested · last 10y
ALKS +1.1% (+0.1%/yr)IONS +50.0% (+4.1%/yr)IONS compounded faster over this window
100200300Start $10020182020202220242026$101$150
ALKS IONS

ALKS vs IONS: by the numbers

  • •IONS is the larger company ($7.31B vs $6.99B market cap).
  • •ALKS is profitable (3.97% net margin) while IONS runs a net loss (-64.64%).
  • •ALKS grew revenue faster over the past five years (8.68% vs 4.91% CAGR).

Metrics side by side

Valuation

MetricALKSIONS
P/E ratio108.75N/A
P/S ratio4.198.37
P/B ratio3.8616.63
EV / EBITDA44.982.21
FCF yield3.17%N/A

Profitability

MetricALKSIONS
Gross margin84.56%98.16%
Operating margin17.21%-40.47%
Net margin3.97%-64.64%
ROE3.66%-128.44%
ROIC2.12%-20.37%

Growth (annualized)

MetricALKSIONS
Revenue CAGR (5Y)8.68%4.91%
FCF CAGR (5Y)20.00%N/A
Total return CAGR (5Y)6.73%5.82%

Frequently asked

Which has grown faster, ALKS or IONS?
Over the past five years, ALKS grew revenue faster — ALKS at a 8.68% CAGR versus IONS at 4.91%.
Is ALKS or IONS more profitable?
ALKS runs the higher net margin — ALKS at 3.97% versus IONS at -64.64%.
How have ALKS and IONS total returns compared?
Over the past 10 years, ALKS delivered -0.82% and IONS delivered 1.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.